Discuva
is a pharmaceutical company that is involved in developing anti-microbial drugs for new emerging and drug-resistant pathogens... Read moreDiscuva
is a pharmaceutical company that is involved in developing anti-microbial drugs for new emerging and drug-resistant pathogens... Read more
News
Jan 03, 2018
Business Weekly
Discuva: Cambridge bug-buster sold for £10m but Roche milestones will still kick-in
Dec 31, 2017
Brief Report
Discuva: TRADER TIPS: Experts say buy drugs firm Summit Therapeutics after £10m deal but sell holiday operator TUI
Dec 27, 2017
Proactive Investors
Discuva: Summit confirms £10mln acquisition of antibiotics discovery group Discuva
Dec 27, 2017
Interactive Investor
Discuva: Summit Therapeutics Buys Antibiotics Firm Discuva For GBP10 Million (ALLISS)
Feb 21, 2017
BioSpace
Discuva: Discuva Announces Extension Of Ongoing Pharma Collaboration To Combat Life-Threatening Infections Caused By Multi-Drug Resistant Bacteria
Jan 26, 2017
Manufacturing Chemist
Discuva: Discuva given grant to address multidrug resistance
Mar 01, 2014
BIOCENTURY
Discuva: Roche, Discuva in antibiotics deal
Discuva Competitors
1
2
3
4
5
6
7
8
9
10